Bijan Moshaver
- Hematology top 2%
- Molecular Biology
- Oncology
- Immunology
- Genetics top 10%
- Co-authors
- Sonja ZweegmanAnna van RhenenN FellerGert J. OssenkoppeleGerrit Jan SchuurhuisGuus A.M.S. van DongenElwin RomboutsAngèle Kelder
- Topics
- Acute Myeloid Leukemia Research (11 papers)Chronic Lymphocytic Leukemia Research (5 papers)Hematopoietic Stem Cell Transplantation (5 papers)
- Cited by
- HematologyImmunologyGenetics
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Bijan Moshaver
19 papers receiving 735 citations
Peers
Comparison fields: 5 of 57
- Hematology 437
- Molecular Biology 253
- Oncology 225
- Immunology 210
- Genetics 99
Countries citing papers authored by Bijan Moshaver
This map shows the geographic impact of Bijan Moshaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bijan Moshaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bijan Moshaver more than expected).
Fields of papers citing papers by Bijan Moshaver
This network shows the impact of papers produced by Bijan Moshaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bijan Moshaver. The network helps show where Bijan Moshaver may publish in the future.
Co-authorship network of co-authors of Bijan Moshaver
This figure shows the co-authorship network connecting the top 25 collaborators of Bijan Moshaver. A scholar is included among the top collaborators of Bijan Moshaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bijan Moshaver. Bijan Moshaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 12 | |
| 3 | 13 | |
| 4 | 8 | |
| 5 | 32 | |
| 6 | 11 | |
| 7 | 9 | |
| 8 | 14 | |
| 9 | 7 | |
| 10 | 19 | |
| 11 | 83 | |
| 12 | 144 | |
| 13 | 5 | |
| 14 | 319 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells. | 30 |
| 20 | Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. | 32 |
About Bijan Moshaver
Bijan Moshaver is a scholar working on Hematology, Genetics and Immunology, having authored 20 papers that have together received 743 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Hematology (437 citations), Immunology (210 citations) and Genetics (99 citations). Bijan Moshaver has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Sonja Zweegman, Anna van Rhenen, N Feller, Gert J. Ossenkoppele, Gerrit Jan Schuurhuis, Guus A.M.S. van Dongen, Elwin Rombouts, Angèle Kelder, G.J. Ossenkoppele and Aggie Nieuwint. Their work appears in journals such as Blood, Stem Cells and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.